Long-term reductions in disease impact in patients with chronic migraine following preventive treatment with eptinezumab.

Blumenfeld A, Ettrup A, Hirman J, Ebert B, Cady R.

DOI: 10.1186/s12883-022-02774-3
Published: 2022-07-08
Container: BMC Neurol
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12883-022-02774-3,
  title = {Long-term reductions in disease impact in patients with chronic migraine following preventive treatment with eptinezumab.},
  author = {Blumenfeld A and  Ettrup A and  Hirman J and  Ebert B and  Cady R.},
  year = {2022},
  journal = {BMC Neurol},
  doi = {10.1186/s12883-022-02774-3},
  url = {https://doi.org/10.1186/s12883-022-02774-3}
}

RIS

TY  - JOUR
TI  - Long-term reductions in disease impact in patients with chronic migraine following preventive treatment with eptinezumab.
AU  - Blumenfeld A
AU  -  Ettrup A
AU  -  Hirman J
AU  -  Ebert B
AU  -  Cady R.
PY  - 2022
JO  - BMC Neurol
DO  - 10.1186/s12883-022-02774-3
UR  - https://doi.org/10.1186/s12883-022-02774-3
ER  -

APA

A, B., A, E., J, H., B, E., & R., C. (2022). Long-term reductions in disease impact in patients with chronic migraine following preventive treatment with eptinezumab.. BMC Neurol. https://doi.org/10.1186/s12883-022-02774-3

Source records

europe-pmc · retrieved 2026-09-26T22:49:33.135Z